Summary
Infusion of hypertonic solutions into the carotid artery is one method by which the blood-brain barrier (BBB) can be opened transiently in experimental animals. This technique has also been tried in clinical situations in which an enhanced uptake of intravenously injected chemotherapeutic drugs into the brain is desired. We have previously found that infusion of hypertonic mannitol or urea into the carotid artery of the rat, leading to a BBB opening, is associated with light microscopic signs of cellular damage in the brain parenchyma. An electron microscopic study has now been made to obtain more detailed information about the events taking place in the rat brain 1 to 72 h after an intracarotid infusion of hyperosmolar solution of mannitol. Toluidine blue-stained semithin epon sections were also available for high-resolution light microscopy of brain samples from urea-infused animals. Intravenously injected Evan's blue dye was used to confirm that BBB opening had occurred as a consequence of the carotid infusions. The infused hemispheres had numerous structural changes. The dominating light microscopic alteration was the presence of multifocal lesions in the gray or the white matter with closely packed microvacuoles causing status spongiosus. Ultrastructurally the microvacuoles corresponded to very pronounced watery swelling of astrocytic processes and to a minor degree to expansion of dendrites and axons. There was also a light or moderate perivascular astrocytic swelling. In the “spongy” lesions as well as occasionally in non-vacuolated parts of the cerebral cortex, there were collapsed electron-dense neurons with pronounced mitochondrial alterations such as severe swelling associated with rupture of christae. Rats with a survival period of 24 h or 72 h showed several disintegrating neurons and accumulation of macrophages. This study shows that carotid infusion of hypertonic mannitol in the rat may cause pronounced neuronal changes as well as multifocal astrocytic swelling. The severity of the nerve cell changes and the presence of macrophages indicate that some of the alterations are irreversible and thus, such a procedure may not be as safe as previously suggested.
Similar content being viewed by others
References
Auer RN, Kalimo H, Olsson Y, Siesjö BK (1985) The temporal evolution of hypoglycemic brain injury. Acta Neuropathol (Berl) 67:13–24
Beck DW, Hart MN, Hansen KE (1984) Effect of intracarotid hyperosmolar mannitol on cerebral cortical arterioles. A morphometric study. Stroke 15:134–136
Bradbury MWB (1979) The concept of a blood-brain barrier. Wiley, Chichester, pp 1–465
Bradbury MWB (1985) The blood-brain barrier. Transport across the cerebral endothelium. Circ Res 57:213–222
Brightman MW, Hori M, Rapoport SI, Reese TS, Westergaard E (1973) Osmotic opening of tight junctions in cerebral endothelium. J Comp Neurol 152:317–325
Crone C (1986) The blood-brain barrier; a modified tight epithelium. In: Suckling AJ, Rumsby MG, Bradbury MWB (eds) The blood-brain barrier in health and disease. Horwood, Chichester, pp 17–40
Goldstein GW, Betz AL (1986) The blood-brain barrier. Sci Am 255:70–79
Neuwelt EA, Frenkel EP, Diehl J, Vu LH, Rapoport SI, Hill S (1980) Reversible osmotic blood-brain barrier disruption in human: implications for the chemotherapy of malignant brain tumors. Neurosurgery 7:44–52
Neuwelt EA, Pagel M, Barnett P, Glassberg M, Frenkel EP (1981) Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification. Cancer Res 41:4466–4470
Neuwelt EA, Specht HD, Howieson J, Haines JE, Bennett MJ, Hill SA, Frenkel EP (1983) Osmotic blood-brain barrier modification: clinical documentation by enhanced CT-scanning and/or radionucleid brain scanning. Am J Neuroradiol 4:907–913
Neuwelt EA, Howieson J, Frenkel EP, Specht HD, Weigel R, Buchan CG, Hill SA (1986) Therapeutic efficacy of multiagent chemotherapy with drug delivery enhancement by blood-brain barrier modification in glioblastoma. Neurosurgery 19:573–582
Neuwelt EA, Specht D, Barnett PA, Dahlborg SA, Miley A, Larson SM, Brown P, Eckerman KF, Hellström KE, Hellström I (1987) Increased delivery of tumor-specific monoclonal antibodies to the brain after osmotic blood-brain barrier modifications in patients with melanoma metastatic to the brain. Neurosurgery 20:885–896
Pardridge WM (1986) Blood-brain barrier: interface between internal medicine and the brain. Ann Intern Med 105:82–95
Pappius HM, Savaki HE, Fieschi C, Rapoport SI, Solokoff L (1979) Osmotic opening of the blood brain barrier and local cerebral glucose utilization. Ann Neurol 5:211–219
Rapoport SI (1970) Effect of concentrated solutions on blood-brain barrier. Am J Physiol 219:270–274
Rapoport SI (1976) Blood-brain barrier in physiology and medicine. Raven Press, New York, pp 1–316
Rapoport WI (1978) Osmotic opening of the blood-brain barrier. In: Elliott K, O'Connor M (eds) Cerebral vascular smooth muscle and its control. Ciba Foundation Symp 56 (new ser). Elsevier/Excerpta Medica/North-Holland, Amsterdam, pp 237–254
Rapoport SI, Bachman DS, Thompson HK (1972) Chronic effects of osmotic opening of the blood-brain barrier in the monkey. Science 176:1243–1244
Rapoport SI, Ohata M, London ED (1981) Cerebral blood flow and glucose utilization following opening of the blood-brain barrier and during maturation of the rat brain. Fed Proc 40:2322–2325
Rapoport SI, London ED, Fredericks WR, Dow-Edwards DI, Mahone PR (1981) Altered cerebral glucose utilization following blood brain barrier opening by hypertonicity or hypertension. Exp Neurol 74:519–529
Salahuddin TS, Sokrab TEO, Kalimo H, Johansson BB, Olsson Y (1988) Immunohistochemical observations on the distribution of plasma proteins in the nervous system. Acta Neurol Scand (in press)
Salahuddin TS, Kalimo H, Johansson B, Olsson Y (1988) Observations on exsudation of fibronectin, fibrinogen and albumin in the brain after carotid infusion of hyperosmolar solutions. Acta Neuropathol 76:1–10
Salahuddin TS, Kalimo H, Johansson BB, Olsson Y (1988) Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. A light and immunohistochemical study. J Appl Neurobiol Neuropathol (in press)
Spigelman MK, Zappulla RA, Strauchen JA, Feuer EJ, Johnson J, Goldsmith SJ, Malis LI, Holland JF (1986) Etoposide induced blood-brain barrier disruption: duration of opening and histological sequelae. Cancer Res 46:1453–1457
Tomiwa K, Hazama K, Mikawa H (1982) Reversible osmotic opening of the blood-brain barrier. Prevention of tissue damage with filtration of the perfusate. Acta Pathol Jpn 32:427–435
Van Deurs (1980) Structural aspects of brain barriers, with special reference to the permeability of the cerebral endothelium and choroidal epithelium. Int Rev Cytol 65:117–191
Author information
Authors and Affiliations
Additional information
Supported by grants from the Swedish Medical Research Council Projects No. 12X-03020, 12X-07123, 14X-04968, Trygg-Hansa, Bergwalls stiftelse, the Swedish Multipel Sclerosis Society and Finnish Medical Research Council
Rights and permissions
About this article
Cite this article
Salahuddin, T.S., Johansson, B.B., Kalimo, H. et al. Structural changes in the rat brain after carotid infusions of hyperosmolar solutions. Acta Neuropathol 77, 5–13 (1988). https://doi.org/10.1007/BF00688236
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00688236